March 26, 2018
C2W recorded revenue for the financial year ended December 31, 2017 of US$11,775 relative to US$66,749 in 2016. Of total revenue, fees and royalties amounted to US$7,153 relative to US$40,569 in 2016. Other income for the year closed at US$4,622 compared to US$26,180. For the quarter, the company recorded revenue of US$6,188 compared to US$51.393 reported in 2016.
C2W incurred US$308,698 for total expenses, a 1629 surge compared to US$17,849 last year.
Consequently, C2W reported an operating loss for the year of US$296,923, versus an operating profit of US$48,900 booked in 2016. Operating loss for the fourth quarter totalled US$276,060 in contrast to a profit of US$59,752 for the prior year’s corresponding period.
The company recorded finance cost of US$6,722 for the year relative to US$6,327 the for the prior year’s corresponding period.
No taxes were recorded for the period. As such, the loss for the period was US$303,645, this compares with the US$42,573 net profit booked for the same period the year prior. For the quarter the company recorded loss of US$277,560 relative to a profit of US$48,572 for the same quarter of 2016.
Loss per share amounted to US0.076 cents, compared to the 2016 earnings per share of US$.011 cents for the comparable period of 2016. The number of shares used in our calculations is 400,000,000.
As December 31, 2017, assets totalled US$11,477, 96% less than the US$315,456 recorded last year. The decrease was mainly due to a decline in both Plant and Equipment (73%) and Advances to Songwriters (100%).
Shareholder’s deficit closed at a US$236,531 compared to a shareholder’s equity of US$67,114 the prior year’s period. This resulted in a negative book value per share of US$0.0591 cents compared to US$0.0168 cents a year earlier.
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.